Osteoblasts on rod shaped hydroxyapatite nanoparticles incorporated pcl film provide an optimal osteogenic niche for stem cell differentiation

Tissue Engineering - Part A

Volumn 17, Issue 11-12, 2011, Pages 1651-1661

  Lu, Zufu ^a   Roohani Esfahani, Seyed Iman ^a   Kwok, Philip Chi Lip ^a   Zreiqat, Hala ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; BIOMATERIALS; BONE; CELL CULTURE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HYDROXYAPATITE; NANOPARTICLES; OPTIMIZATION; PHOSPHORYLATION; PROTEINS; SELF ASSEMBLY; SPHERES; STEM CELLS; TISSUE;

ADIPOSE TISSUE-DERIVED MESENCHYMAL STEM CELLS; BONE BIOMATERIALS; BONE MORPHOGENIC PROTEIN; BONE SIALOPROTEINS; CO-CULTURE SYSTEM; COCULTURE; IMPLANT SURFACE; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; OSSEOINTEGRATION; OSTEOBLASTIC DIFFERENTIATION; OSTEOCALCIN; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; POLY(E-CAPROLACTONE); PRIMARY HUMAN OSTEOBLASTS; PROTEIN EXPRESSIONS; PROTEIN LEVEL; ROD-SHAPED; STEM CELL DIFFERENTIATION; UP-REGULATION;

OSTEOBLASTS;

BONE MORPHOGENETIC PROTEIN 2; HYDROXYAPATITE; ION; NANOPARTICLE; POLYCAPROLACTONE; POLYESTER; SMAD1 PROTEIN; SMAD1 PROTEIN, HUMAN; SMAD5 PROTEIN; SMAD5 PROTEIN, HUMAN;

ADIPOSE TISSUE; ARTICLE; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CHEMISTRY; COCULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; OSTEOBLAST; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL NICHE; SURFACE PROPERTY; ULTRASTRUCTURE;

ADIPOSE TISSUE; BONE MORPHOGENETIC PROTEIN 2; CELL ADHESION; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DURAPATITE; HUMANS; IONS; MESENCHYMAL STEM CELLS; NANOPARTICLES; OSTEOBLASTS; OSTEOGENESIS; POLYESTERS; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; STEM CELL NICHE; STEM CELLS; SURFACE PROPERTIES;

EID: 79957593919     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0567     Document Type: Article

References (49)

1. Ruiz-Hitzky, E., Darder, M., Aranda, P., and Ariga, K. Advances in biomimetic and nanostructured biohybrid materials. Adv Mater 22, 323, 2010.
2. Stylios, G., Wan, T., and Giannoudis, P. Present status and future potential of enhancing bone healing using nanotechnology. Injury 38, S63, 2007.
3. Jung, D.R., Kapur, R., Adams, T., Giuliano, K.A., Mrksich, M., Craighead, H.G., and Taylor, D.L. Topographical and physicochemical modification of material surface to enable patterning of living cells. Crit Rev Biotechnol 21, 111, 2001.
4. Roohani-Esfahani, S.I., Nouri-Khorasani, S., Lu, Z., Appleyard, R., and Zreiqat, H. The influence hydroxyapatite nanoparticle shape and size on the properties of biphasic calcium phosphate scaffolds coated with hydroxyapatite-PCL composites. Biomaterials 31, 5498, 2010.
5. Webster, T.J., Ergun, C., Doremus, R.H., Siegel, R.W., and Bizios, R. Enhanced functions of osteoblasts on nanophase ceramics. Biomaterials 21, 1803, 2000.
6. Dalby, M.J., Gadegaard, N., Curtis, A.S., and Oreffo, R.O. Nanotopographical control of human osteoprogenitor differentiation. Curr Stem Cell Res Ther 2, 129, 2007.
7. Oh, S., Brammer, K.S., Li, Y.S., Teng, D., Engler, A.J., Chien, S., and Jin, S. Stem cell fate dictated solely by altered nanotube dimension. Proc Natl Acad Sci USA 106, 2130, 2009.
8. Pennisi, C.P., Sevcencu, C., Dolatshahi-Pirouz, A., Foss, M., Hansen, J.L., Larsen, A.N., Zachar, V., Besenbacher, F., and Yoshida, K. Responses of fibroblasts and glial cells to nanostructured platinum surfaces. Nanotechnology 20, 385103, 2009.
9. Yim, E.K., Darling, E.M., Kulangara, K., Guilak, F., and Leong, K.W. Nanotopography-induced changes in focal adhesions, cytoskeletal organization, and mechanical properties of human mesenchymal stem cells. Biomaterials 31, 1299, 2010.
10. Yin, Z., Chen, X., Chen, J.L., Shen, W.L., Hieu Nguyen, T.M., Gao, L., and Ouyang, H.W. The regulation of tendon stem cell differentiation by the alignment of nanofibers. Biomaterials 31, 2163, 2010.
11. Oh, S.H., Finones, R.R., Daraio, C., Chen, L.H., and Jin, S. Growth of nano-scale hydroxyapatite using chemically treated titanium oxide nanotubes. Biomaterials 26, 4938, 2005.
12. Cancedda, R., Bianchi, G., Derubeis, A., and Quarto, R. Cell therapy for bone disease: a review of current status. Stem Cells 21, 610, 2003.
13. Murphy, W.L., Hsiong, S., Richardson, T.P., Simmons, C.A., and Mooney, D.J. Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials 26, 303, 2005.
14. Zuk, P.A., Zhu, M., Mizuno, H., Huang, J., Futrell, J.W., Katz, A.J., Benhaim, P., Lorenz, H.P., and Hedrick, M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7, 211, 2001.
15. Alhadlaq, A., and Mao, J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev 13, 436, 2004.
16. Marie, P.J., and Fromigue, O. Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1, 539, 2006.
17. Arinzeh, T.L., Peter, S.J., Archambault, M.P., and Van Den Bos, C., Gordon, S., Kraus, K., Smith, A., Kadiyala, S. Allogeneic mesenchymal stem cells regenerate bone in a criticalsized canine segmental defect. J Bone Joint Surg Am 85-A, 1927, 2003.
18. Huang, Q., Goh, J.C., Hutmacher, D.W., and Lee, E.H. In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor beta1 and the potential for in situ chondrogenesis. Tissue Eng 8, 469, 2002.
19. Jimbo, R., Sawase, T., Shibata, Y., Hirata, K., Hishikawa, Y., Tanaka, Y., Bessho, K., Ikeda, T., and Atsuta, M. Enhanced osseointegration by the chemotactic activity of plasma fibronectin for cellular fibronectin positive cells. Biomaterials 28, 3469, 2007.
20. Lee, D.H., Park, B.J., Lee, M.S., Lee, J.W., Kim, J.K., Yang, H.C., and Park, J.C. Chemotactic migration of human mesenchymal stem cells and MC3T3-E1 osteoblast-like cells induced by COS-7 cell line expressing rhBMP-7. Tissue Eng 12, 1577, 2006.
21. Rose, F.R., and Oreffo, R.O. Bone tissue engineering: hope vs hype. Biochem Biophys Res Commun 292, 1, 2002.
22. Csaki, C., Matis, U., Mobasheri, A., and Shakibaei, M. Coculture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation. Histochem Cell Biol 131, 251, 2009.
23. Ilmer, M., Karow, M., Geissler, C., Jochum, M., and Neth, P. Human osteoblast-derived factors induce early osteogenic markers in human mesenchymal stem cells. Tissue Eng Part A 15, 2397, 2009.
24. Wang, Y., Volloch, V., Pindrus, M.A., Blasioli, D.J., Chen, J., and Kaplan, D.L. Murine osteoblasts regulate mesenchymal stem cells via WNT and cadherin pathways: mechanism depends on cell-cell contact mode. J Tissue Eng Regen Med 1, 39, 2007.
25. Boyan, B.D., Batzer, R., Kieswetter, K., Liu, Y., Cochran, D.L., Szmuckler-Moncler, S., Dean, D.D., and Schwartz, Z. Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1 alpha,25-(OH)2D3. J Biomed Mater Res 39, 77, 1998.
26. Olivares-Navarrete, R., Hyzy, S.L., Hutton, D.L., Erdman, C.P., Wieland, M., Boyan, B.D., and Schwartz, Z. Direct and indirect effects of microstructured titanium substrates on the induction of mesenchymal stem cell differentiation towards the osteoblast lineage. Biomaterials 31, 2728, 2010.
27. Ong, J.L., Bess, E.G., and Bessho, K. Osteoblast progenitor cell responses to characterized titanium surfaces in the presence of bone morphogenetic protein-atelopeptide type I collagen in vitro. J Oral Implantol 25, 95, 1999.
28. Lu Z., and Zreiqat, H. The osteoconductivity of biomaterials is regulated by bone morphogenetic protein 2 autocrine loop involving a2b1 integrin and mitogen-activated protein kinase/ extracellular related kinase signaling pathways. Tissue Eng Part A 16, 3075, 2010.
29. Zreiqat, H., Valenzuela, S.M., Nissan, B.B., Roest, R., Knabe, C., Radlanski, R.J., Renz, H., and Evans, P.J. The effect of surface chemistry modification of titanium alloy on signalling pathways in human osteoblasts. Biomaterials 26, 7579, 2005.
30. Czyz, J., and Wobus, A. Embryonic stem cell differentiation: the role of extracellular factors. Differentiation 68, 167, 2001.
31. Discher, D.E., Mooney, D.J., and Zandstra, P.W. Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673, 2009.
32. LaBarge, M.A., Nelson, C.M., Villadsen, R., Fridriksdottir, A., Ruth, J.R., Stampfer, M.R., Petersen, O.W., and Bissell, M.J. Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments. Integr Biol (Camb) 1, 70, 2009.
33. Lu, Z.F., Doulabi, B.Z., Wuisman, P.I., Bank, R.A., and Helder, M.N. Influence of collagen type II and nucleus pulposus cells on aggregation and differentiation of adipose tissue-derived stem cells. J Cell Mol Med 12, 2812, 2008.
34. Yamashita, A., Nishikawa, S., and Rancourt, D.E. Microenvironment modulates osteogenic cell lineage commitment in differentiated embryonic stem cells. PLoS One 5, e9663, 2010.
35. Taubenberger, A.V., Woodruff, M.A., Bai, H., Muller, D.J., and Hutmacher, D.W. The effect of unlocking RGD-motifs in collagen I on pre-osteoblast adhesion and differentiation. Biomaterials 31, 2827, 2010.
36. Miron, R.J., Oates, C.J., Molenberg, A., Dard, M., and Hamilton, D.W. The effect of enamel matrix proteins on the spreading, proliferation and differentiation of osteoblasts cultured on titanium surfaces. Biomaterials 31, 449, 2010.
37. Park, I.S., Han, M., Rhie, J.W., Kim, S.H., Jung, Y., and Kim, I.H. The correlation between human adipose-derived stem cells differentiation and cell adhesion mechanism. Biomaterials 30, 6835, 2009.
38. Falconnet, D., Csucs, G., Grandin, H.M., and Textor, M. Surface engineering approaches to micropattern surfaces for cell-based assays. Biomaterials 27, 3044, 2006.
39. Giannoni, P., Muraglia, A., Giordano, C., Narcisi, R., Cancedda, R., Quarto, R., and Chiesa, R. Osteogenic differentiation of human mesenchymal stromal cells on surfacemodified titanium alloys for orthopedic and dental implants. Int J Artif Organs 32, 811, 2009.
40. Hidalgo-Bastida, L.A., and Cartmell, S.H. Mesenchymal stem cells, osteoblasts and extracellular matrix proteins: enhancing cell adhesion and differentiation for bone tissue engineering. Tissue Eng Part B Rev 16, 405, 2010.
41. Wang, C., Karlis, G.A., Anderson, G.I., Dunstan, C.R., Carbone, A., Berger, G., Ploska, U., and Zreiqat, H. Bone growth is enhanced by novel bioceramic coatings on Ti alloy implants. J Biomed Mater Res A 90, 419, 2009.
42. Kilian, K.A., Bugarija, B., Lahn, B.T., and Mrksich, M. Geometric cues for directing the differentiation of mesenchymal stem cells. Proc Natl Acad Sci USA 107, 4872, 2010.
43. Binulal, N.S., Deepthy, M., Selvamurugan, N., Shalumon, K.T., Suja, S., Mony, U., Jayakumar, R., and Nair, S.V. Role of nanofibrous poly(Caprolactone) scaffolds in human mesenchymal stem cell attachment and spreading for in vitro bone tissue engineering-response to osteogenic regulators. Tissue Eng Part A 16, 393, 2010.
44. Lu, Z.F., Zandieh Doulabi, B., Wuisman, P.I., Bank, R.A., and Helder, M.N. Differentiation of adipose stem cells by nucleus pulposus cells: configuration effect. Biochem Biophys Res Commun 359, 991, 2007.
45. Rosen, V. BMP2 signaling in bone development and repair. Cytokine Growth Factor Rev 20, 475, 2009.
46. Javed, A., Bae, J.S., Afzal, F., Gutierrez, S., Pratap, J., Zaidi, S.K., Lou, Y., Van Wijnen, A.J., Stein, J.L., Stein, G.S., and Lian, J.B. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 283, 8412, 2008.
47. Ishibashi, O., Ikegame, M., Takizawa, F., Yoshizawa, T., Moksed, M.A., Iizawa, F., Mera, H., Matsuda, A., and Kawashima, H. Endoglin is involved in BMP-2-induced osteogenic differentiation of periodontal ligament cells through a pathway independent of Smad-1/5/8 phosphorylation. J Cell Physiol 222, 465, 2009.
48. Jadlowiec, J.A., Zhang, X., Li, J., Campbell, P.G., and Sfeir, C. Extracellular matrix-mediated signaling by dentin phosphophoryn involves activation of the Smad pathway independent of bone morphogenetic protein. J Biol Chem 281, 5341, 2006.
49. Yue, J., Frey, R.S., and Mulder, K.M. Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene 18, 2033, 1999.